News | May 25, 2022
Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
The key categories include intimate wellness, skincare & hair care
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Subscribe To Our Newsletter & Stay Updated
